Venkataraman V, Martin-Giacalone BA, Drake BF, Salmi L, Claus EB, Schuster ALR, Bridges JFP, Lenz HJ, Willman CL, Diehl D, Janeway KA, Mack JW, and George S. Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality. Journal of Clinical Oncology (2024): JCO-24. doi: 10.1200/JCO.24.00347

Chaudhuri A. A. (2023). Cell-Free DNA Liquid Biopsy: The Epitome of Personalized Precision Oncology. Radiation research, 200(1), 92–95. https://doi.org/10.1667/RADE-23-00044.1

Claus, E. B., & Verhaak, R. G. W. (2023). Targeting IDH in Low-Grade Glioma. The New England journal of medicine, 389(7), 655–659. https://doi.org/10.1056/NEJMe2305602

Earland, N., Chen, K., Semenkovich, N. P., Chauhan, P. S., Zevallos, J. P., & Chaudhuri, A. A. (2023). Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology. Seminars in radiation oncology, 33(3), 262–278. https://doi.org/10.1016/j.semradonc.2023.03.004

Heffernan, A. E., Wu, Y., Benz, L. S., Verhaak, R. G. W., Kwan, B. M., & Claus, E. B. (2023). Quality of life after surgery for lower grade gliomas. Cancer, 10.1002/cncr.34980. Advance online publication. https://doi.org/10.1002/cncr.34980

Mack J. W. (2023). The Day One Talk, 20 Years Later: What Have We Learned?. JCO oncology practice, 19(4), 164–166. https://doi.org/10.1200/OP.23.00005

Rodriguez, N. J., Ricker, C., Stoffel, E. M., & Syngal, S. (2023). Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21(1), 3–7. https://doi.org/10.1016/j.cgh.2022.10.025

Schork, N. J., Beaulieu-Jones, B., Liang, W. S., Smalley, S., & Goetz, L. H. (2023). Exploring human biology with N-of-1 clinical trials. Cambridge prisms, Precision medicine, 1, e12. https://doi.org/10.1017/pcm.2022.15

Schuster ALR, Crossnohere NL, Bachini M, Blair CK, Carpten JD, Claus EB, Colditz GA, Ding L, Drake BF, Fields RC, Janeway KA, Kwan BM, Lenz HJ, Ma Q, Mishra SI, Paskett ED, Rebbeck TR, Ricker C, Stern MC, Sussman AL, Tiner JC, Trent JM, Verhaak RGW, Wagle N, Willman C, Bridges JFP, for the PE-CGS Network. Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. Cancer Epidemiol Biomarkers Prev. 2023;32:4(487-495). doi: 10.1158/1055-9965.EPI-22-0356

Schuster ALR, Hampel H, Paskett ED, Bridges JFP. Rethinking patient engagement in cancer research. Patient 16, 89–93 (2023). https://doi.org/10.1007/s40271-022-00604-9

Schuster, A. L. R., Crossnohere, N. L., Paskett, J., Thomas, N., Hampel, H., Ma, Q., Tiner, J. C., Paskett, E. D., & Bridges, J. F. P. (2023). Promoting patient engagement in cancer genomics research programs: An environmental scan. Frontiers in genetics, 14, 1053613. https://doi.org/10.3389/fgene.2023.1053613

Semenkovich, N. P., Szymanski, J. J., Earland, N., Chauhan, P. S., Pellini, B., & Chaudhuri, A. A. (2023). Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA. Journal for immunotherapy of cancer, 11(6), e006284. https://doi.org/10.1136/jitc-2022-006284

Postel, M. D., Culver, J. O., Ricker, C., & Craig, D. W. (2022). Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum. Human mutation, 43(11), 1590–1608. https://doi.org/10.1002/humu.24394

Rebbeck TR, Bridges JFP, Mack JW, Gray SW, Trent JM, George S, Crossnohere NL, Paskett ED, Painter CA, Wagle N, Kano M, Nez Henderson P, Henderson JA, Mishra SI, Willman CL, Sussman AL. A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research. JAMA Health Forum. 2022;3(4):e220603. doi:10.1001/jamahealthforum.2022.0603

Varn, F. S., Johnson, K. C., Martinek, J., Huse, J. T., Nasrallah, M. P., Wesseling, P., Cooper, L. A. D., Malta, T. M., Wade, T. E., Sabedot, T. S., Brat, D., Gould, P. V., Wöehrer, A., Aldape, K., Ismail, A., Sivajothi, S. K., Barthel, F. P., Kim, H., Kocakavuk, E., Ahmed, N., … GLASS Consortium (2022). Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell, 185(12), 2184–2199.e16. https://doi.org/10.1016/j.cell.2022.04.038

PE-CGS_PublicationPolicy_v8.0

Advancing Data Sharing through the Cancer Moonshot - Kai Tan, PhD & Liz Salmi (OPTIMUM)

Count Me In: Partnering with Patients to Define the Landscape of Rare, Aggressive Sarcomas - Katherine Janeway, MD (Count Me In)

Engagement of American Indians of Southwest Tribal Nations in Cancer Genome Sequencing - Cheryl Willman, MD & Jeffery M. Trent, PhD (JUNIPER)

This Unique Network Closes Research Gaps in Cancer Genomics - Bettina Drake, PhD (WU-PE-CGS) & Leah Mechanic, PhD

LinkedIn:

Participant Engagement & Cancer Genome Sequencing (PE-CGS) Network

https://www.linkedin.com/company/participant-engagement-cancer-genome-sequencing-pe-cgs-network/

Twitter: @PECGSnetwork

To sign up, go to the pecgs.org website, click on the 'PE-CGS Member Repository' button in the upper right corner, and select 'Create an Account'. Enter and submit your account information. After creating an account, please reach out to the Coordinating Center (pe-cgs@osumc.edu) for access. 

If you had an account prior to the new website launch, you do not have to go through this process again.

All PE-CGS Network members are invited to join the dedicated PE-CGS Workspace on Slack. There you will find a general area to chat about topics relevant to whole Network, as well as separate channels devoted to each subcommittee. 

Review the Getting Started guide and learn how to use Slack, if it's new to you. It might be helpful to adjust your preferences for notifications.

Join the PE-CGS Slack here